EDITORIAL article
Front. Endocrinol.
Sec. Bone Research
This article is part of the Research TopicStem Cells and Extracellular Vesicles in Bone Health, Disease and Regeneration - Volume IIView all 5 articles
Editorial: Stem Cells and Extracellular Vesicles in Bone Health, Disease and Regeneration - Volume II
Provisionally accepted
- 1State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Xi'an, China
- 2Xi'an Jiao Tong University Stomatology Hospital, Xi'an, China
- 3Stanford University Stanford Institute for Stem Cell Biology and Regenerative Medicine, Stanford, United States
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
considerable medical burden on society (1)(2)(3)(4). However, currently available therapeutic strategies for these conditions are neither cost-effective nor easily accessible (5).Notably, medications used to treat osteoporosis are associated with rare complications such as osteonecrosis of the jaw and atypical femoral fracture (depending it on long term therapy), while effective methods for bone regeneration fall short in addressing severe infections and large-scale defects (6). In preclinical studies, various sources of stem cells, particularly mesenchymal stem cells (MSCs), have been utilized in the treatment of osteoporosis and the promotion of bone regeneration, yielding certain positive outcomes (1). Furthermore, extracellular vesicles (EVs) have garnered extensive attention recently for their potential in treating bone diseases due to their cellfree nature, low immunogenicity, and capacity to carry a diverse array of effective molecules and drugs (1,7). This Research Topic aims to explore and summarize the most cutting-edge advancements in this field. It seeks to provide the latest foundational insights into bone diseases while contributing to efforts aimed at maintaining optimal bone health. With the progression of aging, osteoporosis, a prevalent manifestation of skeletal senescence closely associated with impaired bone homeostasis, inevitably occurs. Collectively, these contributions synthesize recent cutting-edge progress in the use of MSCs and EVs for degenerative bone diseases and bone defects, elucidating their modes of action and highlighting their clinical promise in managing skeletal disorders.
Keywords: Bone, extracellular vesicles, mesenchymal stem cell, Osteoporosis, Regeneration
Received: 05 Nov 2025; Accepted: 10 Dec 2025.
Copyright: © 2025 Ma, Liang, Bai, Zhao and Sui. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Bingdong Sui
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.